Cargando…

Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine

Achieving a cure for high-risk neuroblastoma, the most common extracranial solid tumor in children, remains a formidable task despite the recent addition of antibody-mediated anti-GD2 immunotherapy to established multimodality therapy. The PI3K/Akt pathway is a pivotal signaling pathway utilized by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Weili, Modak, Shakeel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299554/ https://www.ncbi.nlm.nih.gov/pubmed/22419878 http://dx.doi.org/10.2147/OTT.S14578

Ejemplares similares

Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma
por: Gu, Xiao, et al.
Publicado: (2017)

Perifosine as a potential novel anti-telomerase therapy
por: Holohan, Brody, et al.
Publicado: (2015)

Potential Treatment Options for Neuroblastoma with Polyphenols through Anti-Proliferative and Apoptotic Mechanisms
por: Kafoud, Aisha, et al.
Publicado: (2023)

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
por: Becher, Oren J., et al.
Publicado: (2017)

Genome-wide identification of genetic determinants for the cytotoxicity of perifosine
por: Zhang, Wei, et al.
Publicado: (2008)

Emerging treatment options for short bowel syndrome: potential role of teduglutide
por: Tee, Cheng T, et al.
Publicado: (2011)

Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
por: Shaw, Heather M, et al.
Publicado: (2013)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
por: Kaley, Thomas J., et al.
Publicado: (2020)

Synergistic cytotoxicity of perifosine and ABT‐737 to colon cancer cells
por: Adamová, Barbora, et al.
Publicado: (2022)

The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo
por: Gao, Yuanhong, et al.
Publicado: (2011)

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells
por: Gong, Baocheng, et al.
Publicado: (2021)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023)

Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
por: Jain, Rohit K, et al.
Publicado: (2020)

Emerging treatment options for nasopharyngeal carcinoma
por: Zhang, Lu, et al.
Publicado: (2013)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

Inhibition of Glutathione and Thioredoxin Metabolism Enhances Sensitivity to Perifosine in Head and Neck Cancer Cells
por: Simons, Andrean L., et al.
Publicado: (2009)

Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis
por: Pavlatovská, Barbora, et al.
Publicado: (2020)

Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2012)

The Role of Intracellular Calcium for the Development and Treatment of Neuroblastoma
por: Satheesh, Noothan Jyothi, et al.
Publicado: (2015)

Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine
por: Gills, J J, et al.
Publicado: (2012)

Current and emerging treatment options for nasopharyngeal carcinoma
por: Spratt, Daniel E, et al.
Publicado: (2012)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu, Meghna, et al.
Publicado: (2011)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Emerging treatment options for early mycosis fungoides
por: Fernandez-Guarino, Montserrat
Publicado: (2013)

Current and emerging treatment options for Peyronie’s disease
por: Gokce, Ahmet, et al.
Publicado: (2013)

Current and emerging treatment options for uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2013)

Emerging treatment options for meibomian gland dysfunction
por: Qiao, Jing, et al.
Publicado: (2013)

Birdshot uveitis: current and emerging treatment options
por: Menezo, Victor, et al.
Publicado: (2014)

Acquired hemophilia A: emerging treatment options
por: Janbain, Maissaa, et al.
Publicado: (2015)

Emerging treatment options for myelofibrosis: focus on pacritinib
por: Chow, Vivian, et al.
Publicado: (2016)

Chemophototherapy: An Emerging Treatment Option for Solid Tumors
por: Luo, Dandan, et al.
Publicado: (2016)

Emerging options for the treatment of melanoma – focus on ipilimumab
por: Roddie, Claire, et al.
Publicado: (2014)

Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016)

Emerging treatment options for the management of pemphigus vulgaris
por: Kridin, Khalaf
Publicado: (2018)

Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
por: Cives, Mauro, et al.
Publicado: (2020)

Emerging Treatment Options for Myelofibrosis: Focus on Anemia
por: Sastow, Dahniel, et al.
Publicado: (2023)

Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression
por: FAWZY, MOHAMED, et al.
Publicado: (2015)

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
por: Lenert, Aleksander, et al.
Publicado: (2015)

Current and Emerging Treatment Options for Fecal Incontinence
por: Rao, Satish S.C.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_spv36bpbcdbv31s3961upbvgde